Cargando…

Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma

Elevated urinary 3-methoxytyramine (3MT) level at diagnosis was recently put forward as independent risk factor for poor prognosis in neuroblastoma. Here, we investigated the biologic basis underlying the putative association between elevated 3MT levels and poor prognosis. METHODS: Urinary 3MT level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verly, Iedan R. N., Matser, Yvette A. H., Leen, René, Meinsma, Rutger, Fiocco, Marta, Koster, Jan, Volckmann, Richard, Savci-Heijink, Dilara, Cangemi, Giuliana, Barco, Sebastiano, Valentijn, Linda J., Tytgat, Godelieve A. M., van Kuilenburg, André B. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2022
Materias:	Original Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830522/ https://www.ncbi.nlm.nih.gov/pubmed/35085004 http://dx.doi.org/10.1200/PO.20.00447

Ejemplares similares

Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake
por: Blom, Thomas, et al.
Publicado: (2020)

Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
por: Blom, Thomas, et al.
Publicado: (2021)

The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator
por: Sotnikova, Tatyana D., et al.
Publicado: (2010)

A high sensitivity LC-MS/MS method for measurement of 3-methoxytyramine in plasma and associations between 3-methoxytyramine, metanephrines, and dopamine
por: Smy, Laura, et al.
Publicado: (2021)

Correction: The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator
por: Sotnikova, Tatyana D., et al.
Publicado: (2010)

A novel gene expression signature for bone metastasis in breast carcinomas
por: Savci-Heijink, C. Dilara, et al.
Publicado: (2016)

Association between gene expression profile of the primary tumor and chemotherapy response of metastatic breast cancer
por: Savci-Heijink, Cemile Dilara, et al.
Publicado: (2017)

Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma
por: Rao, Dipti, et al.
Publicado: (2017)

Plasma free metanephrine, normetanephrine, and 3-methoxytyramine for the diagnosis of pheochromocytoma/paraganglioma
por: Gupta, Poonam, et al.
Publicado: (2015)

Neurofibromatosis-related phaeochromocytoma: two cases with large tumours and elevated plasma methoxytyramine
por: Teasdale, Stephanie, et al.
Publicado: (2015)

Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma
por: Hussein, Ziad, et al.
Publicado: (2021)

Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine
por: Richter, Susan, et al.
Publicado: (2022)

Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma
por: Cuperus, Roos, et al.
Publicado: (2009)

A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma
por: van Groningen, Tim, et al.
Publicado: (2019)

Biological Fluid Microsampling for Therapeutic Drug Monitoring: A Narrative Review
por: Cafaro, Alessia, et al.
Publicado: (2023)

Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics
por: van Gerven, Michael R., et al.
Publicado: (2022)

Development of an Accurate Mass Retention Time Database for Untargeted Metabolomic Analysis and Its Application to Plasma and Urine Pediatric Samples
por: Lavarello, Chiara, et al.
Publicado: (2021)

Hypermethylated RASSF1A as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma
por: van Zogchel, Lieke M. J., et al.
Publicado: (2020)

Dual-Template Magnetic Molecularly Imprinted Polymer for Simultaneous Determination of Spot Urine Metanephrines and 3-Methoxytyramine for the Diagnosis of Pheochromocytomas and Paragangliomas
por: Zeng, Hongyu, et al.
Publicado: (2022)

Alternative pathway for dopamine production by acetogenic gut bacteria that O‐Demethylate 3‐Methoxytyramine, a metabolite of catechol O‐Methyltransferase
por: Rich, Barry E., et al.
Publicado: (2022)

Inadequate detection of the FSHR complicates future research on extragonadal FSHR localization
por: Tedjawirja, Victoria N., et al.
Publicado: (2023)

Plasma Levels of Soluble HLA-E and HLA-F at Diagnosis May Predict Overall Survival of Neuroblastoma Patients
por: Morandi, Fabio, et al.
Publicado: (2013)

Cannabidiol Determination on Peripheral Capillary Blood Using a Microsampling Method and Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry with On-Line Sample Preparation
por: Pigliasco, Federica, et al.
Publicado: (2020)

Development and Validation of a Novel LC-MS/MS Method for a TDM-Guided Personalization of HSCT Conditioning with High-Dose Busulfan in Children
por: Cafaro, Alessia, et al.
Publicado: (2023)

The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2
por: Sarkisjan, Dzjemma, et al.
Publicado: (2016)

A specific gene expression signature for visceral organ metastasis in breast cancer
por: Savci-Heijink, C. D., et al.
Publicado: (2019)

A UHPLC–MS/MS Method for Therapeutic Drug Monitoring of Aciclovir and Ganciclovir in Plasma and Dried Plasma Spots
por: Pigliasco, Federica, et al.
Publicado: (2021)

Retrospective analysis of metastatic behaviour of breast cancer subtypes
por: Savci-Heijink, C. Dilara, et al.
Publicado: (2015)

A Volumetric Absorptive Microsampling Technique to Monitor Cannabidiol Levels in Epilepsy Patients
por: Dubois, Sara, et al.
Publicado: (2020)

A Novel LC–MS/MS-Based Method for the Diagnosis of ADA2 Deficiency from Dried Plasma Spot
por: Cafaro, Alessia, et al.
Publicado: (2021)

Histopathology: ditch the slides, because digital and 3D are on show
por: Jansen, Ilaria, et al.
Publicado: (2018)

IL-10 and ARG-1 Concentrations in Bone Marrow and Peripheral Blood of Metastatic Neuroblastoma Patients Do Not Associate with Clinical Outcome
por: Morandi, Fabio, et al.
Publicado: (2015)

Untargeted LC-HRMS Based-Plasma Metabolomics Reveals 3-O-Methyldopa as a New Biomarker of Poor Prognosis in High-Risk Neuroblastoma
por: Barco, Sebastiano, et al.
Publicado: (2022)

Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior
por: Savci-Heijink, C. D., et al.
Publicado: (2019)

MYC regulates metabolism through vesicular transfer of glycolytic kinases
por: Tsakaneli, Alexia, et al.
Publicado: (2021)

Deep learning for automatic Gleason pattern classification for grade group determination of prostate biopsies
por: Lucas, Marit, et al.
Publicado: (2019)

UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations
por: Malaca, Sara, et al.
Publicado: (2021)

Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma
por: Cangemi, Giuliana, et al.
Publicado: (2012)

Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method
por: Pigliasco, Federica, et al.
Publicado: (2023)

Fluorescence in situ hybridization in 1 mL of selective urine for the detection of upper tract urothelial carcinoma: a feasibility study
por: Freund, J. E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rl1hp4bel8db8bo4chf457pc40